Ticker Launch

SPAC · Merger completed

Newcourt Acquisition Corp

Business combination with Psyence Biomed Corp.

Newcourt Acquisition Corp is a blank-check company (SPAC) that raised $220M in its initial public offering on Oct 21, 2021, listing on Nasdaq Global Market. It completed its business combination with Psyence Biomed Corp. on Jan 25, 2024; the combined company is Psyence Biomedical Ltd. (PBM). Cantor led the IPO. Reed Smith advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.

Status
Merger completed
IPO date
Oct 21, 2021
IPO size
$220M
IPO exchange
Nasdaq Global Market
Target
Psyence Biomed Corp.
Announced
Jan 10, 2023
Stated deal value
$50M
Closed
Jan 25, 2024
Combined company
Psyence Biomedical Ltd. (PBM)
IPO underwriters
Cantor
SPAC counsel (IPO)
Reed Smith and Maples and Calder
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2024